These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7651177)

  • 1. Expression cloning strategies for glycosylphosphatidylinositol-anchor biosynthesis enzymes and regulators.
    Kinoshita T; Miyata T; Inoue N; Takeda J
    Methods Enzymol; 1995; 250():547-60. PubMed ID: 7651177
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression cloning of genes for GPI-anchor biosynthesis.
    Kinoshita T; Takahashi M; Inoue N; Miyata T; Takeda J
    Braz J Med Biol Res; 1994 Feb; 27(2):127-32. PubMed ID: 8081220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A system utilizing Epstein-Barr virus-based expression vectors for the functional cloning of human fibroblast growth regulators.
    Carstens CP; Gallo JC; Maher VM; McCormick JJ; Fahl WE
    Gene; 1995 Oct; 164(2):195-202. PubMed ID: 7590331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
    Cachianes G; Ho C; Weber RF; Williams SR; Goeddel DV; Leung DW
    Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter.
    Contreras-Brodin B; Karlsson A; Nilsson T; Rymo L; Klein G
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1159-62. PubMed ID: 8683201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression, purification, and crystallization of the DNA binding and dimerization domains of the Epstein-Barr virus nuclear antigen 1.
    Barwell JA; Bochkarev A; Pfuetzner RA; Tong H; Yang DS; Frappier L; Edwards AM
    J Biol Chem; 1995 Sep; 270(35):20556-9. PubMed ID: 7657632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an EBNA-producing line of well-differentiated human hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors.
    Lutfalla G; Armbruster L; Dequin S; Bertolotti R
    Gene; 1989 Mar; 76(1):27-39. PubMed ID: 2545532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cDNA clones that modify radiomimetic sensitivity of ataxia-telangiectasia (group A) cells.
    Ziv Y; Bar-Shira A; Jorgensen TJ; Russell PS; Sartiel A; Shows TB; Eddy RL; Buchwald M; Legerski R; Schimke RT; Shiloh Y
    Somat Cell Mol Genet; 1995 Mar; 21(2):99-111. PubMed ID: 7570189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of a human gene, PIG-F, a component of glycosylphosphatidylinositol anchor biosynthesis, by a novel expression cloning strategy.
    Inoue N; Kinoshita T; Orii T; Takeda J
    J Biol Chem; 1993 Apr; 268(10):6882-5. PubMed ID: 8463218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus vectors for gene delivery to B lymphocytes.
    Robertson ES; Ooka T; Kieff ED
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11334-40. PubMed ID: 8876136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
    Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW
    Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
    Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated expression of Epstein-Barr virus nuclear antigen 3-encoding gene carried on stable episomal vectors in human cells.
    James MR; Sarasin AR; Perricaudet M; Joab I
    Gene; 1990 Feb; 86(2):233-9. PubMed ID: 2157631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors.
    Vidal M; Wrighton C; Eccles S; Burke J; Grosveld F
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):171-7. PubMed ID: 2157493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.
    Belt PB; Groeneveld H; Teubel WJ; van de Putte P; Backendorf C
    Gene; 1989 Dec; 84(2):407-17. PubMed ID: 2482230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
    Curiel TJ; Cook DR; Bogedain C; Jilg W; Harrison GS; Cotten M; Curiel DT; Wagner E
    Virology; 1994 Feb; 198(2):577-85. PubMed ID: 8291240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
    Burgstahler R; Kempkes B; Steube K; Lipp M
    Biochem Biophys Res Commun; 1995 Oct; 215(2):737-43. PubMed ID: 7488016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.